⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Genestack and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Genestack
↗Cambridge, United Kingdom
Genestack is a global leader in life science R&D informatics, specializing in multi-omics data management and integration software. The company provides a platform that helps pharmaceutical, agriscience, and consumer goods organizations harmonize, curate, and analyze siloed biological data to accelerate drug discovery and translational research.
Founded in 2012 as a joint venture with JetBrains, Genestack focuses on addressing data science bottlenecks in R&D. Its flagship product, Omics Data Manager (ODM), enables organizations to create and manage large catalogs of life science datasets, making them AI-ready and queryable for researchers and bioinformaticians.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Bioinformatics & R&D Informatics
SIZE & FINANCIALS
Employees:11-50
Revenue:$3M-$5M
Founded:2012
Ownership:private
Status:operating
FUNDING
Stage:Private
Investors:JetBrains
0
CORPORATE STRUCTURE
Key Partnerships:Milner Therapeutics Institute (Data management and analysis), Bejo (Multi-omics data solution implementation), JetBrains (Joint venture partner)
COMPETITION
Position:Niche Player
Competitors:DNAnexus, Benchling, Sophia Genetics, Genomenon
LEADERSHIP
Key Executives:
Misha Kapushesky - CEO
Katia Kapushesky - Chief Operating Officer
Dmitriy Pavlov - Head of Engineering
Scientific Founders:Misha Kapushesky
Board Members:Sergey Dmitriev
LINKS
Website:genestack.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Genestack. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.